Description

Swiss Pharmaceuticals Tesofensine 250 mcg – 60 Capsules

Swiss Pharmaceuticals Tesofensine is presented as a capsule product containing a reported 250 mcg of tesofensine per capsule. Retail listings identify the package as containing 60 capsules. This page provides neutral ingredient, research and safety information and should not be interpreted as medical advice or confirmation that the product is authorised for sale in any particular country.

The declared active ingredient should be verified against the original product label, manufacturer specification and batch certificate of analysis. The available product information does not clearly establish whether the ingredient is supplied as tesofensine free base, tesofensine citrate or another chemical form. Inactive ingredients, capsule material, allergens and manufacturing details must be copied directly from verified packaging.

Reported Product Information

What Is Tesofensine?

Tesofensine, also known by the development code NS2330, is a synthetic compound belonging to the phenyltropane chemical family. It has been investigated as a serotonin, noradrenaline and dopamine reuptake inhibitor, sometimes abbreviated as an SNDRI.

By influencing monoamine transporters, tesofensine can affect neurotransmitter activity in the central nervous system. Research programmes have examined its potential effects on appetite regulation, food-seeking behaviour and body-weight management. These research findings do not establish that a commercially supplied capsule product is an approved medicine or that it has demonstrated the same identity, purity or clinical performance as material used in controlled studies.

Chemical Identity

The molecular formula reported for tesofensine free base is C17H23Cl2NO. The compound is distinct from peptides, vitamins, minerals, amino acids and herbal extracts. It should not be described as a peptide, despite occasionally being placed in peptide or research-compound categories by online sellers.

Tesofensine citrate is a separate salt form with a different molecular formula and molecular weight. For accurate product documentation, the label should clearly state which form is present and whether the declared 250 mcg refers to the complete salt or to the tesofensine-equivalent quantity.

Research and Regulatory Status

Tesofensine has undergone clinical investigation in people with obesity and in combination-development programmes. Its development history does not automatically permit it to be marketed as a food supplement, cosmetic product or general weight-management capsule.

Regulatory classification may differ between countries. Depending on the composition, claims and intended use, a tesofensine product may be regarded as an investigational substance, an unauthorised medicinal product or another regulated product. The responsible seller should verify marketing authorisation, import requirements, online-sales restrictions and permitted claims in every destination market.

Safety Considerations

Clinical investigations of tesofensine have reported effects on heart rate and blood pressure. Other reported adverse effects in research settings have included dry mouth, sleep disturbances, nausea, headache and gastrointestinal symptoms. The compound may also interact with medicines or substances affecting serotonin, noradrenaline, dopamine, blood pressure or heart rhythm.

Individuals taking antidepressants, stimulants, monoamine oxidase inhibitors, blood-pressure medication or other centrally acting medicines require professional medical assessment. Combining monoaminergic substances without medical supervision may create serious health risks.

This product should not be used during pregnancy or breastfeeding. It should be kept out of reach of children and should not be used by individuals with cardiovascular, neurological, psychiatric or uncontrolled blood-pressure conditions without qualified medical supervision.

Product Verification Notice

Before publishing or distributing this product, verify the complete front and rear labels, exact chemical form, serving information, capsule count, inactive ingredients, allergens, manufacturer identity, batch number, expiry date, storage conditions and certificate of analysis.

The product must not be promoted using guaranteed weight-loss claims, medical treatment claims, before-and-after promises or statements implying that it is approved by European regulatory authorities unless suitable documentary evidence is available.

Disclaimer: This description is provided solely for ingredient identification, regulatory review and general educational purposes. It is not a recommendation to use tesofensine, a dosage instruction or confirmation that Swiss Pharmaceuticals Tesofensine is authorised as a medicine or food supplement.